Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): NZ$56.6 M

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are NZ$57.63 M. In 2022 the company made an earning of NZ$0.10 B an increase over its 2021 earnings that were of -NZ$4.71 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year	Earnings	Change
2023 (TTM)	NZ$56.6 M	-46.84%
2022	NZ$0.10 B	-2361.45%
2021	-NZ$4.71 M	-111.53%
2020	NZ$40.81 M	2.31%
2019	NZ$39.89 M	-32.89%
2018	NZ$59.44 M	-50.35%
2017	NZ$0.11 B	38.63%
2016	NZ$86.37 M	1966.43%
2015	NZ$4.17 M	-111.46%
2014	-NZ$36.49 M	282.82%
2013	-NZ$9.54 M

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Johnson & Johnson JNJ	NZ$32.76 B	56,752.41%	🇺🇸 USA
GlaxoSmithKline GSK	NZ$10.13 B	17,482.38%	🇬🇧 UK
Novartis NVS	NZ$17.61 B	30,464.51%	🇨🇭 Switzerland
Teva Pharmaceutical Industries TEVA	NZ$1.33 B	2,219.19%	🇮🇱 Israel
Amgen AMGN	NZ$5.69 B	9,785.30%	🇺🇸 USA
Eli Lilly LLY	NZ$14.53 B	25,109.06%	🇺🇸 USA
Bristol-Myers Squibb BMY	-NZ$10.38 B	-18,101.07%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): NZ$56.6 M